Epigral shares surged sharply by over 10% in early trade on Monday, even as the company reported a mixed set of numbers for the fourth quarter of FY26.
Strong Revenue Growth Drives Sentiment
For Q4FY26, Epigral reported consolidated revenue of Rs. 736 crore, marking a solid 17.3% year-on-year (YoY) increase compared to Rs. 628 crore in the same quarter last year.
Margins Under Pressure
While revenue growth remained strong, profitability showed signs of strain. EBITDA declined 2.8% YoY to Rs. 169 crore from Rs. 173 crore. More notably, EBITDA margin contracted sharply to 22.9% from 27.6% a year ago, suggesting rising input costs or pricing pressure.
Net profit also slipped 6.8% YoY to Rs. 80.9 crore, compared to Rs. 86.9 crore in Q4FY25. The decline in earnings highlights the impact of margin compression on the bottom line.
Dividend Announcement Adds Cheer
Despite the dip in profits, Epigral announced a final dividend of Rs. 5 per share, which supported investor sentiment and contributed to the stock’s sharp rally.